Novel therapies for postoperative nausea and vomiting: Statistically significant versus clinically meaningful outcomes

Anesthesia and Analgesia

Volumn 112, Issue 4, 2011, Pages 750-752

  Scuderi, Phillip E ^a   White, Paul F ^b,c,d  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c Policlinico Abano   (Italy)

^d White Mountain Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APREPITANT; DEXAMETHASONE; DROPERIDOL; GRANISETRON; NEUROKININ 1 RECEPTOR ANTAGONIST; ONDANSETRON; PALONOSETRON; PLACEBO; ROLAPITANT; SCOPOLAMINE;

DRUG EFFICACY; DRUG SAFETY; INCIDENCE; MONOTHERAPY; OUTCOME ASSESSMENT; POSTOPERATIVE NAUSEA AND VOMITING; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; VOMITING;

EID: 79953172306     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ANE.0b013e31820d979c     Document Type: Editorial

References (19)

1. Watcha MF, White PF. Postoperative nausea and vomiting: its etiology, treatment, and prevention. Anesthesiology 1992; 77:162-84
2. Gesztesi Z, Scuderi PE, White PF, Wright W, Wender RH, D'Angelo R, Black LS, Dalby PL, MacLean D. Substance P (neurokinin-1) antagonist prevents postoperative vomiting after abdominal hysterectomy procedures. Anesthesiology 2000;93:931-7
3. Diemunsch P, Joshi GP, Brichant JF. Neurokinin-1 receptor antagonists in the prevention of postoperative nausea and vomiting. Br J Anaesth 2009;103:7-13
4. Diemunsch P, Apfel C, Gan TJ, Candiotti K, Philip BK, Chelly J, Carides AD, Evans JK, Ho TW, Reiss T. Preventing postoperative nausea and vomiting: post hoc analysis of pooled data from two randomized active-controlled trials of aprepitant. Curr Med Res Opin 2007;23:2559-65 (Pubitemid 350033458)
5. Diemunsch P, Gan TJ, Philip BK, Girao MJ, Eberhart L, Irwin MG, Pueyo J, Chelly JE, Carides AD, Reiss T, Evans JK, Lawson FC; Aprepitant-PONV Protocol 091 International Study Group. Single-dose aprepitant vs ondansetron for the prevention of postoperative nausea and vomiting: a randomized, doubleblind phase III trial in patients undergoing open abdominal surgery. Br J Anaesth 2007;99:202-11 (Pubitemid 47260214)
6. Diemunsch P, Schoeffler P, Bryssine B, Cheli-Muller LE, Lees J, McQuade BA, Spraggs CF. Antiemetic activity of the NK1 receptor antagonist GR205171 in the treatment of established postoperative nausea and vomiting after major gynaecological surgery. Br J Anaesth 1999;82:274-6 (Pubitemid 29057630)
7. Gan TJ, Apfel CC, Kovac A, Philip BK, Singla N, Minkowitz H, Habib AS, Knighton J, Carides AD, Zhang H, Horgan KJ, Evans JK, Lawson FC; Aprepitant-PONV Study Group. A randomized, double-blind comparison of the NK1 antagonist, aprepitant, versus ondansetron for the prevention of postoperative nausea and vomiting. Anesth Analg 2007;104:1082-9 (Pubitemid 46649925)
8. Gan TJ, Gu J, Singla N, Chung F, Pearman MH, Bergese SD, Habib AS, Candiotti KA, Huyck S, Creed MR, Cantillon M. Rolapitant for the prevention of postoperative nausea and vomiting: a prospective double-blinded, placebo-controlled randomized trial. Anesth Analg 2011;112:804-12
9. Apfel CC, Korttila K, Abdalla M, Kerger H, Turan A, Vedder I, Zernak C, Danner K, Jokela R, Pocock SJ, Trenkler S, Kredel M, Biedler A, Sessler DI, Roewer N; IMPACT Investigators. A factorial trial of six interventions for the prevention of postoperative nausea and vomiting. N Engl J Med 2004;350:2441-51
10. Tang J, Wang B, White PF, Watcha MF, Qi J, Wender RH. The effect of timing of ondansetron administration on its efficacy, cost-effectiveness, and cost-benefit as a prophylactic antiemetic in the ambulatory setting. Anesth Analg 1998;86:274-82 (Pubitemid 28079475)
11. White PF, Kehlet H. Improving postoperative pain management:what are the unresolved issues? Anesthesiology 2010;112:220-5
12. Yogendran S, Asokumar B, Cheng DC, Chung F. A prospective randomized double-blinded study of the effect of intravenous fluid therapy on adverse outcomes on outpatient surgery. Anesth Analg 1995;80:682-6
13. White PF, Tang J, Song D, Coleman JE, Wender RH, Ogunnaike B, Sloninsky A. Transdermal scopolamine: an alternative to ondansetron and droperidol for the prevention of postoperative emetic symptoms. Anesth Analg 2007;104:92-6 (Pubitemid 46360427)
14. D'Angelo R, Philip B, Gan TJ, Kovac A, Hantler C, Doblar D, Melson T, Minkowitz H, Dalby P, Coop A. A randomized, double-blind, dose-ranging, pilot study of intravenous granisetron in the prevention of postoperative nausea and vomiting in patients undergoing abdominal hysterectomy. Eur J Anaesthesiol 2005;22:774-9 (Pubitemid 41391654)
15. Candiotti KA, Kovac AL, Melson TI, Clerici G, Joo GT. A randomized, double-blind study to evaluate the efficacy and safety of three different doses of palonosetron versus placebo for preventing postoperative nausea and vomiting. Anesth Analg 2008;107:445-51
16. Tang J, D'Angelo R, White PF, Scuderi PE. The efficacy of RS-25259, a long-acting selective 5-HT3 receptor antagonist, for preventing postoperative nausea and vomiting after hysterectomy procedures. Anesth Analg 1998;87:462-7 (Pubitemid 28369112)
17. Scuderi PE, James RL, Harris L, Mims GR III. Multimodal antiemetic management prevents early postoperative vomiting after outpatient laparoscopy. Anesth Analg 2000;91:1408-14
18. White PF. Prevention of postoperative nausea and vomiting: a multimodal solution to a persistent problem. N Engl J Med 2004;350:2511-2 (Pubitemid 38736549)
19. Zárate E, Mingus M, White PF, Chiu JW, Scuderi P, Loskota W, Daneshgari V. The use of transcutaneous acupoint electrical stimulation for preventing nausea and vomiting after laparoscopic surgery. Anesth Analg 2001;92:629-35 (Pubitemid 32185102)